Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02535078
Brief Title: Phase 1b/2 Study of the Combination of IMCgp100 With Durvalumab and/or Tremelimumab in Cutaneous Melanoma

First Submitted : August 26, 2015
First Submitted that Met QC Criteria : August 27, 2015
First Posted : August 28, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : April 9, 2021
Last Update Posted : April 14, 2021 (Estimate)